[Clinical and biological effectiveness of antiretroviral therapy in the ANRS 1215 cohort] - Debeaudrap, Pierre; Diouf, A.; Bousso Niang, K. (Bull Soc Pathol Exot, 2014)
In 1998, the cohort ANRS 1215 was launched in Senegal with one of the first African antiretroviral treatment programs. Four hundred forty four HIV-infected adults started on ART were included between 1998 and 2004, and followed up to 2010. Mortality before 6 months was 15.6/100 person-year (PY) and associated to the initial disease severity. It decreased to 3.36/100 PY thereafter. The cumulative risks of virologic failure at 60 months and of drug resistance at 48 months were 25% and 16%, respectively.
00001 Bulletin de la Societe de pathologie exotique (1990)
Keywords: journalArticle; *Antiretroviral Therapy, Highly Active; Adult; Anti-HIV Agents/*therapeutic use; Cohort Studies; Female; HIV Infections/diagnosis/*drug therapy/epidemiology; Humans; Male; Prognosis; Senegal/epidemiology; Survival Analysis; Treatment Outcome; ⚠️ Invalid DOI